Archives de l’auteur : oxeltis
Oxeltis is pleased to take part to the AFSSI annual meeting on preclinical research on July 3rd, in Marseille. Come and join us to talk about your current or future fine chemistry and medicinal chemistry projects.
Oxeltis is present at BIO International Convention in Boston (MA), USA ! We look forward to seeing you there. For any appointments you can check our profile on One on One Partnering or send us an email : firstname.lastname@example.org.
Oxeltis is at Meet2Win, Oncology business convention in Bordeaux, May 17-18. Come to discuss your current and future projects involving medicinal chemistry (FTE contracts for Hit selection & optimization, H2L work, Lead optimization…) and small molecule custom synthesis. See you … Continuer la lecture
Oxeltis will be present at OncoWeek Toulouse, looking forward meeting you email@example.com
Oxeltis is pleased to announce to its customers and R&D partners the renewal of its agreement for R&D tax credit (agrément Crédit Impôt Recherche) by the French Ministry of Higher Education and Research for years 2017, 2018 and 2019. … Continuer la lecture
Position: Post Doc (PhD) in Organic Synthesis / Medicinal Chemistry in Montpellier (France) – fix term contract 12 months, starting Feb-March 2017 The Post Doc in medicinal chemistry will be responsible for the proposal, synthesis, characterization and study of heterocyclic and … Continuer la lecture